Matches in Wikidata for { <http://www.wikidata.org/entity/Q99572246> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q99572246 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99572246 description "scientific article published on 18 September 2020" @default.
- Q99572246 description "wetenschappelijk artikel" @default.
- Q99572246 description "наукова стаття, опублікована 18 вересня 2020" @default.
- Q99572246 name "Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphisms" @default.
- Q99572246 name "Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphisms" @default.
- Q99572246 type Item @default.
- Q99572246 label "Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphisms" @default.
- Q99572246 label "Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphisms" @default.
- Q99572246 prefLabel "Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphisms" @default.
- Q99572246 prefLabel "Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphisms" @default.
- Q99572246 P1433 Q99572246-20F28710-EA87-4158-B0BF-9CFC74DCA58F @default.
- Q99572246 P1476 Q99572246-AE8BF30F-2338-469D-AF91-EECA80273C21 @default.
- Q99572246 P2093 Q99572246-4F3F428F-0534-40F8-BD14-DC21919B83D3 @default.
- Q99572246 P2093 Q99572246-5E7E796A-3FB6-4BFF-9F1D-2E6491239CB2 @default.
- Q99572246 P2093 Q99572246-601068A0-7BB0-469B-A9E0-84D6C6116299 @default.
- Q99572246 P2093 Q99572246-66523431-D397-481C-B5C3-AC4838EC3F7B @default.
- Q99572246 P2093 Q99572246-787A2635-8395-419F-BC01-3B509B73D57F @default.
- Q99572246 P2093 Q99572246-A5DA59D8-5D2C-47BC-B4D1-4B1764C629FE @default.
- Q99572246 P2093 Q99572246-BC961E09-2E35-4E27-BBAF-61896EB78723 @default.
- Q99572246 P2093 Q99572246-EA60BA87-8EAF-4246-9C80-A1B338459550 @default.
- Q99572246 P31 Q99572246-185E8C80-802A-4951-816C-6CA392259CD9 @default.
- Q99572246 P356 Q99572246-31526190-17CF-4BFD-98CC-88330823D33E @default.
- Q99572246 P50 Q99572246-8CE74853-81D6-426A-9409-A48A74129F65 @default.
- Q99572246 P577 Q99572246-FABB1562-070E-4DDD-8669-25360BE9A68B @default.
- Q99572246 P698 Q99572246-B8FB3FA5-7013-4976-8560-95F9EA72A484 @default.
- Q99572246 P356 S00280-020-04136-7 @default.
- Q99572246 P698 32948919 @default.
- Q99572246 P1433 Q326137 @default.
- Q99572246 P1476 "Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphisms" @default.
- Q99572246 P2093 "Ken Uchibori" @default.
- Q99572246 P2093 "Kenichi Tadokoro" @default.
- Q99572246 P2093 "Naoya Fujita" @default.
- Q99572246 P2093 "Noriko Yanagitani" @default.
- Q99572246 P2093 "Ryo Ariyasu" @default.
- Q99572246 P2093 "Ryohei Katayama" @default.
- Q99572246 P2093 "Satoru Kitazono" @default.
- Q99572246 P2093 "Toshikazu Yamaguchi" @default.
- Q99572246 P31 Q13442814 @default.
- Q99572246 P356 "10.1007/S00280-020-04136-7" @default.
- Q99572246 P50 Q90933419 @default.
- Q99572246 P577 "2020-09-18T00:00:00Z" @default.
- Q99572246 P698 "32948919" @default.